Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,228,827
-$4,827,844 QoQ
Shares Held
4,487
-71.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#647
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $18,605,643 across 285 Biotechnology names. VRTX ranks #2 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
37,664 | $2,947,961 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
4,487 | $2,228,827 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,562 | $1,912,615 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,530 | $1,577,556 | |
| 5 | INCY |
Incyte Corp
|
5,182 | $587,431 | |
| 6 | EXEL |
Exelixis, Inc.
|
10,562 | $574,678 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
10,089 | $550,254 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
2,240 | $419,507 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,228,827 | 4,487 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $7,056,671 | 15,803 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,363,360 | 14,036 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,069,177 | 2,730 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $1,541,282 | 3,462 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $943,459 | 1,946 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $701,100 | 1,741 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $766,916 | 1,649 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $826,353 | 1,763 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $500,775 | 1,198 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $465,074 | 1,143 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $376,949 | 1,084 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $320,590 | 911 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $288,289 | 915 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $233,911 | 810 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $201,230 | 695 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $181,190 | 643 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $142,489 | 546 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $117,486 | 535 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $5,441 | 30 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $5,242 | 26 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $5,587 | 26 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $29,778 | 126 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $7,075 | 26 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $7,548 | 26 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $6,186 | 26 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||